Everand Logo

Welcome to Everand!

  • STAT

    Opinion: The lab leak conversation shows it’s time to rethink our biosecurity infrastructure, not just policies

    With biosecurity at the forefront of people’s minds, this is an opportune moment to think differently.
    by Sam Weiss Evans and David Gillum Mar 21, 2023 1 minute
    Biosafety protective suits outside a chemical decontamination room in a biosafety level 4 training facility at U.S. Army Medical Research and Development Command at Fort Detrick in Frederick, Md.

    The Covid pandemic exacerbated fear and panic regarding the potential for a future bioterrorism agent. As the lab leak theory continues to

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

    Related Books & Audiobooks